Fujifilm Renews Fellowship Fund at Harvard Medical School for Translational Science Research

Fujifilm also congratulates the 2021 scholarship recipients

CAMBRIDGE, Mass., December 20, 2021 (GLOBE NEWSWIRE) – FUJIFILM Holdings America Corporation (Fujifilm) today announced that it has renewed its commitment to the Fujifilm Fellowship Fund at Harvard Medical School (HMS) to advance education and research in the field of translational medicine, the process of applying basic laboratory research to new therapeutic developments. The donation will support up to 8 additional doctorates. candidates for HMS until 2024.

Established in 2019, the scholarship program is designed to equip young scientists with the specialist skills needed to translate their research results into cutting-edge medical solutions for patients.

Harvard recently named Kailyn Doiron and Kanae Sasaki the latest Fujifilm Fellow recipients. They follow in the footsteps of 11 previous doctorates. HMS applicants who have been awarded the Fujifilm Fellowships, which provides two years of research funding to promising students from the nine HMS-based Life Sciences PhDs. programs. The HMS management selects all the beneficiaries of the program.

“Fujifilm’s strong and dynamic partnership with Harvard Medical School continues to thrive as we work diligently towards a common goal: the discovery and development of new therapies and treatments for a wide range of unmet medical needs,” said Yutaka Yamaguchi, Director General, Life Sciences. Business Division, Life Sciences Strategy Headquarters, FUJIFILM Corporation; President and CEO, FUJIFILM Irvine Scientific, Inc. “We extend our sincere congratulations to two highly esteemed doctoral students who recently received grants and whose work has the potential to change the lives of patients and their families. “

Like all previous recipients, the last two Fujifilm Fellows represent the school’s most promising doctorate. students:

Kailyn Doiron is a third year doctoral student in Systems Biology, Synthetic and Quantitative. program. She has a background in cellular and molecular biology and a strong passion for research in synthetic biology. Kailyn works in the lab of Pamela Silver, Ph.D., Elliott T. and Onie H. Adams Professor of Biochemistry and Systems Biology at the Blavatnik Institute at HMS. As a member of the Silver Lab, Kailyn will continue to focus on bringing synthetic biology ideas to a place where they can be translated into transformative new drugs for patients. Ultimately, Kailyn strives to develop new protein therapies to address the unmet medical need for safe and effective treatments for chronic and inflammatory pain.

Kanae Sasaki is enrolled in a PhD in Biological and Biomedical Sciences. program. Previously, Kanae gained extensive research experience working as a research assistant throughout her undergraduate years, and later as a research technician at Massachusetts General Hospital in the Joung Lab. She is currently studying gene therapy for a degenerative retinal disease, retinitis pigmentosa (RP), in the lab of Constance Cepko, Ph.D., Bullard Professor of Genetics and Neuroscience at the Blavatnik Institute at HMS. Kanae’s goal is to develop gene therapies that prolong photoreceptor cell survival and which can help RP patients maintain sight and improve their quality of life.

“We are deeply grateful to the academic advisors of the Fujifilm Fellows for their guidance and mentorship in the pursuit of this potentially life-changing translational research,” commented Bruce E. Novich Sc.D., Division President, FUJIFILM Holdings America Corporation . “These scholarships are one of many life sciences partnership initiatives between Fujifilm and Harvard University, all of which continue to inspire us to NEVER STOP advancing the medical sciences. “

In addition to their doctorate. program, Fujifilm Fellows are enrolled in the Therapeutics Graduate Program, a new program focusing on pharmacology, toxicology and drug discovery. Here they receive rigorous multidisciplinary training to identify and develop new therapies, understand and study the mechanisms of action of drugs, analyze the reasons for clinical failures and develop new compounds and apply them in preclinical and clinical studies to improve the disease treatment.

About the Fujifilm scholarship
The Fujifilm Fellowship Program was designed by Fujifilm and HMS to advance translational medicine research by investing in the next generation of scientists. Selected beneficiaries who have been admitted to Harvard Medical School’s graduate program in therapeutics will receive financial assistance to continue their education and research in therapeutic innovation. The HMS management selects all the beneficiaries of the program. For more information, please visit https://www.fujifilmfellowship.com/

About Fujifilm
FUJIFILM Holdings America Corporation is the regional headquarters for the Americas. It is made up of 21 affiliates in North America and Latin America that are engaged in the research, development, manufacture, sale and service of FUJIFILM products and services. The company’s portfolio represents a wide range of industries including medical and life sciences, electronics, chemistry, graphic arts, information systems, industrial products, broadcasting, media. recording and photography. For more information, please visit: https://www.fujifilm.com/us/en/about/region.

FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting-edge solutions to a wide range of global industries by leveraging its in-depth knowledge and foundational technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to various fields including healthcare, highly functional materials, document solutions and imaging products. These products and services are based on its broad portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the fiscal year ended March 31, 2021, the company achieved worldwide revenue of $ 21 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible stewardship of the environment and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.

###
All product and company names mentioned in this document may be trademarks of their registered owners.

CONTACT: Christine Jackman FUJIFILM Holdings America Corporation 9142614959 christine.jackman@fujifilm.com
Source link

About Donald P. Hooten

Check Also

The global fluidics market for preclinical research, life sciences and clinical applications is expected to grow by $ 10.38 billion during the period 2021-2025, growing at a CAGR of 19.10% during the forecast period.

Global Fluidics Market for Preclinical Research, Life Sciences, and Clinical Applications 2021-2025 New York, December …